Clinical Trials Logo

Positional Vertigo clinical trials

View clinical trials related to Positional Vertigo.

Filter by:
  • None
  • Page 1

NCT ID: NCT05141734 Completed - Positional Vertigo Clinical Trials

Correlation Tests for Patients With Benign Paroxysmal Positional Vertigo

Start date: April 15, 2019
Phase:
Study type: Observational

This study aimed to investigate whether there is a relationship between nystagmus intensity and vestibular-ocular reflex gains by comparing Videonystagmography and video head impulse test in patients with posterior semicircular canal-benign paroxysmal positional vertigo.

NCT ID: NCT02615314 Completed - Migraine Clinical Trials

Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine

Start date: January 2015
Phase: N/A
Study type: Observational

The aim of this study is to analyze the clinical aspects of patients with BPPV associated with migraine. It is our purpose to clarify weather migraine is a risk factor for BPPV if the clinical aspect and the therapeutic outcome is different.

NCT ID: NCT00729885 Active, not recruiting - Vertigo Clinical Trials

Visual Feedback Goggle for Positional Vertigo Treatment

Start date: November 2006
Phase: Phase 1/Phase 2
Study type: Interventional

Benign Paroxysmal Positional Vertigo (BPPV) is one of the most common causes of vertigo and the most common vestibular disorder of the inner ear. BPPV is the result of small free-floating particles (canaliths) in the posterior semicircular canals where they aggravate the sensory apparatus and induce sudden and severe attacks of vertigo when the head is turned into certain positions. The treatment of BPPV was revolutionized by the introduction of the Epley maneuver, a sequence of head movements that use gravity to reposition the canaliths within the inner ear. The Epley maneuver provides prompt relief from vertigo in approximately 80% of patients. The innovation, the Vertigone goggle, provides both physician and patient with visual feedback to guide them through an accurate Epley maneuver. This changes the current treatment paradigm for BPPV, greatly increasing the availability of the maneuver to non-specialist physicians, nurse practitioners, physician's assistants and physical therapists. The device is designed so that the patient with recurrent vertigo can use the goggle to treat BPPV at home. The goggle is currently a pre-market prototype. The hypothesis for the study is that accuracy in the performance of the Epley maneuver correlates with improved clinical resolution of vertigo in BPPV patients. If the hypothesis is true, then there is a clear case for the utility of the visual feedback provided by the VertiGONE goggle in performing the maneuver.